angiotensin ii has been researched along with Liver Cirrhosis in 238 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 120 (50.42) | 18.7374 |
| 1990's | 17 (7.14) | 18.2507 |
| 2000's | 47 (19.75) | 29.6817 |
| 2010's | 44 (18.49) | 24.3611 |
| 2020's | 10 (4.20) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, YW; Pang, PJ; Sun, YK | 1 |
| Ge, X; Wang, SN; Wu, Y; Zhang, CQ | 1 |
| Domenig, O; Hartl, L; Hecking, M; Jachs, M; Mandorfer, M; Marculescu, R; Paternostro, R; Poglitsch, M; Reiberger, T; Reindl-Schwaighofer, R; Rumpf, B; Simbrunner, B; Trauner, M | 1 |
| An, Y; Hong, J; Jiang, J; Liu, W; Qiu, H; Sun, W; Wei, W; Xu, C; Yang, M; Ye, P; Yu, J; Yu, M; Zhang, S; Zhu, W | 1 |
| Li, X; Li, Y; Lou, A; Su, L; Tong, H; Zhang, M; Zhu, X | 1 |
| Ainsworth, CR; Chow, JH; Coleman, PJ; Kim, DE; Mazzeffi, MA; McCurdy, MT; Nissen, AP | 1 |
| Li, Z; Wang, S; Wu, Y; Xiu, A; Zhang, C | 1 |
| Cheng, B; Li, S; Liu, C; Zhao, W; Zhao, Z | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Angus, PW; Burrell, LM; Casey, S; Grace, JA | 1 |
| Du, WJ; Fang, PP; Huang, SS; Li, J; Li, Q; Lin, W; Pan, CW; Zhou, GY | 1 |
| Balestrieri, A; Barcellona, D; Caocci, G; Castagnola, M; Cau, R; Coghe, F; Coni, P; D'Andrea, F; Faa, G; Fanni, D; Gerosa, C; La Nasa, G; Ledda, F; Marongiu, F; Orru, G; Piras, M; Ronchi, A; Saba, L; Suri, JS | 1 |
| Bie, P; Fialla, AD; Krag, A; Schaffalitzky de Muckadell, OB; Thiesson, HC | 1 |
| Miranda, AS; Rocha, NP; Simões E Silva, AC; Teixeira, AL | 1 |
| Chen, Q; Hu, Q; Hu, Z; Huang, Y; Mao, Z; Xu, F; Zhou, X | 1 |
| Aihara, Y; Douhara, A; Kaji, K; Kawaratani, H; Kitade, M; Moriya, K; Namisaki, T; Nishimura, N; Noguchi, R; Okura, Y; Sawada, Y; Seki, K; Takeda, K; Yoshiji, H | 1 |
| Hayashi, M; Hirokawa, F; Jin, D; Masubuchi, S; Miyaoka, Y; Ozeki, M; Takai, S; Tashiro, K; Uchiyama, K | 1 |
| Miranda, AS; Simões E Silva, AC | 1 |
| Baik, SK; Eom, YW; Kang, SH; Kim, MY; Shim, KY | 1 |
| Angus, P; Casey, S; Herath, C; Jones, R; Rajapaksha, I | 1 |
| Ma, J; Ma, L; Ou, HL | 1 |
| Beckett, JD; Bedja, D; Butcher, JT; Chen, Y; Creamer, TJ; Dietz, HC; Gould, RA; Hata, S; Kim, DH; MacFarlane, EG; Mitzner, W; Nagpal, V; Rouf, R; Seman-Senderos, MA; Warren, DS | 1 |
| Abd El-Rahman, SS; Fayed, HM | 1 |
| Li, P; Miao, J; Wang, Y; Zhang, W; Zhang, Y | 1 |
| He, C; Li, J; Miao, X; Qi, H | 1 |
| Aagaard, NK; Bech, JN; Pedersen, EB; Pedersen, RS; Sorensen, TB; Vilstrup, H | 1 |
| Baba, A; Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Shimizu, M; Shirakami, Y; Tanaka, T; Terakura, D; Tsurumi, H | 1 |
| Aoyama, T; Bataller, R; Brenner, DA; De Minicis, S; Kim, J; Paik, YH | 1 |
| Li, X; Li, YS; Luo, HH; Meng, Y; Ni, SY; Shi, XL; Zhao, XW | 1 |
| Ikeda, A; Maesawa, C; Masuda, T; Mizugai, H; Nishinari, Y; Nishiya, M; Oikawa, H; Oikawa, K; Takikawa, Y; Tatemichi, Y | 1 |
| Fürst, DO; Gonzalez-Carmona, MA; Görtzen, J; Granzow, M; Huss, S; Klein, S; Knolle, P; Kowallick, B; Krämer, B; Laleman, W; Linhart, M; Mazar, IG; Nattermann, J; Sauerbruch, T; Schierwagen, R; Schildberg, FA; Shah, VH; Siegmund, SV; Trebicka, J; Vogt, A; Werner, N; Wojtalla, A | 1 |
| Kong, Q; Li, H; Mu, L; Qin, X; Shi, K; Shi, L; Sun, B; Wang, G; Wang, J; Wang, X; Zhao, W | 1 |
| Lu, X; Pan, D; Qin, Y; Wang, S; Wang, X; Wu, C; Xu, S; Xu, X; Ye, G | 1 |
| Alexander, IE; Angus, PW; Chin, R; Cunningham, SC; Habib, MR; Herath, CB; Mak, KY; Sharland, AF; Torresi, J | 1 |
| James, PD; Tan, HK; Wong, F | 1 |
| Huang, S; Jin, SY; Li, X; Li, Y; Ma, XX; Wang, D; Zhang, LL; Zhang, WY; Zhang, YP | 1 |
| Huang, S; Jin, SY; Li, X; Li, Y; Ling, XG; Luo, XY; Ma, XX; Ning, ZW; Pan, MX; Wang, D; Wang, GZ; Yang, RQ | 1 |
| Li, S; Liu, C; Tao, Y; Wang, Q | 1 |
| Aragno, M; Mastrocola, R; Mengozzi, G; Novo, E; Parola, M; Sansoè, G | 1 |
| Angus, PW; Burrell, LM; Herath, CB; Lubel, JS | 1 |
| Bataller, R; Moreno, M | 1 |
| Rockey, DC | 2 |
| Almeida, J; Nadu, AP; Ribeiro, Rda C; Ribeiro-Oliveira, A; Santos, RA; Simões e Silva, AC; Vieira, RL; Vilas-Boas, WW | 1 |
| Bataller, R; Ching-A-Sue, G; Colmenero, J; Eliopoulos, AG; Jonsson, JR; Manas, D; Mann, DA; Oakley, F; Teoh, V; Watson, MR | 1 |
| Angus, PW; Burrell, LM; Casley, D; Crowley, P; Grace, J; Herath, CB; Jia, Z; Lubel, JS; Sievert, W; Spencer, K; Tchongue, J | 1 |
| Hu, S; Liu, J; Shen, L; Yang, L; Ye, J; Zhu, R | 1 |
| Pinzani, M | 1 |
| Almeida, J; dos Santos, RA; Nadu, AP; Pereira, RM; Ribeiro, Rda C; Ribeiro-Oliveira, A; Simões e Silva, AC; Vilas-Boas, WW | 1 |
| da Costa Dias, FL; dos Santos, RA; Pereira, RM; Simões e Silva, AC; Teixeira, MM | 1 |
| Heller, J; Hennenberg, M; Kohistani, AZ; Sauerbruch, T; Trebicka, J | 1 |
| Brenner, DA; De Minicis, S; Kluwe, J; Kodama, Y; Osterreicher, CH; Oudit, GY; Penninger, JM; Penz-Osterreicher, M; Schuster, M; Seki, E; Taura, K | 1 |
| Cheng, J; Lan, MD; Liang, YL; Wang, Q; Wei, HS; Xing, HC; Zhang, B | 1 |
| Bataller, R; Colmenero, J; De Minicis, S; Gwak, GY; Kluwe, J; Mencin, A; Osterreicher, CH; Pradere, JP; Schwabe, RF | 1 |
| Cho, BH; Kim, SY; Kim, UH | 1 |
| Chen, YP; Dong, PH; Fan, XF; Li, J; Lin, Z; Yu, FJ | 1 |
| Dell, KM; Goto, M; Hoxha, N; Osman, R; Wells, RG; Wen, J | 1 |
| Patel, K; Thompson, AJ | 1 |
| Bataller, R; Casals, G; Jimenez, W; Melgar-Lesmes, P; Morales-Ruiz, M; Pauta, M; Reichenbach, V; Ros, J | 1 |
| Arteel, GE; Beier, JI; Guo, L; Kaiser, JP; Martínez-Maldonado, M | 1 |
| Horiguchi, N; Ichikawa, T; Izumi, T; Kakizaki, S; Kishimoto, K; Mori, M; Ohyama, T; Sato, K; Takagi, H; Yamazaki, Y | 1 |
| Brenner, DA; Paik, YH | 1 |
| Angus, PW; Burrell, LM; Grace, JA; Herath, CB; Mak, KY | 1 |
| Fletcher, JA; Matthew Morris, E; Rector, RS; Thyfault, JP | 1 |
| Aoyama, T; Brenner, DA; Fioraso-Cartier, L; Gaggini, F; Heitz, F; Laleu, B; Merlot, C; Molango, S; Page, P; Paik, YH; Szyndralewiez, C; Watanabe, S | 1 |
| Chan, CC; Hsieh, YC; Huang, YH; Lee, KC; Lin, HC; Yang, YY | 1 |
| Angus, PW; Burrell, LM; Herath, CB; Mak, K | 1 |
| Aihara, Y; Douhara, A; Fukui, H; Kaji, K; Kawaratani, H; Moriya, K; Namisaki, T; Noguchi, R; Shirai, Y; Yoshiji, H | 1 |
| Hayes, PC; Helmy, A; Jalan, R; Johnston, NR; Newby, DE; Webb, DJ | 1 |
| Jespersen, B; Schaffalitzky de Muckadell, OB; Skøtt, O; Thiesson, HC | 1 |
| Bech, JN; Bentzen, H; Nyvad, O; Pedersen, EB; Pedersen, RS | 1 |
| Chen, XQ; Li, X; Wu, PS; Yang, XS; Yu, ZX; Zhang, XF; Zhang, YJ | 1 |
| Jalan, R; Kapoor, D | 1 |
| Bandyopadhyay, K; Biswas, PK; Das, D; Das, TK; Dasgupta, S; De, BK; Majumdar, D; Mandal, SK; Ray, S | 1 |
| Shen, FJ; Wang, BE; Yin, CH | 1 |
| JOHNSTON, CI; JOSE, AD | 1 |
| KAPLAN, NM; SILAH, JG | 1 |
| HORKY, K; KUECHEL, O; PAZOUREK, M | 2 |
| BISHT, DB; SHYAMALAN, NC; SINGH, SS | 1 |
| AMES, RP; BORKOWSKI, AJ; LARAGH, JH; SICINSKI, AM | 1 |
| Mengozzi, G; Rizzetto, M; Rosina, F; Sansoé, G; Silvano, S; Smedile, A; Todros, L; Touscoz, G | 1 |
| Friedman, SL | 1 |
| Chen, XQ; Liao, GQ; Wu, PS; Yang, GP; Yang, XS; Zhang, XF; Zhang, YJ | 1 |
| Chen, HK; Gu, XB; Liu, XY; Pei, H; Zhu, YF | 1 |
| Hattori, Y; Matsuda, N | 1 |
| Bataller, R; Brenner, DA | 1 |
| Hartner, A; Hilgers, KF; Krause, H; Porst, M; Schmieder, RE; Veelken, R | 1 |
| Bataller, R; Brenner, DA; Gäbele, E; Morris, T; Parsons, CJ; Rippe, RA; Schoonhoven, R; Yang, L | 1 |
| Guo, D; Jiang, B; Lai, ZS; Li, X; Meng, Y; Wang, WW; Yang, XS; Zhang, ZS | 1 |
| Chayama, K; Hyogo, H; Kanno, K; Nishioka, T; Tazuma, S | 1 |
| Barcelos, LS; Collares, GB; Costa, LP; da Costa Dias, FL; Dos Santos, RA; Leite, VH; Pereira, RM; Simões e Silva, AC; Teixeira, MM | 1 |
| Biecker, E; Heller, J; Hennenberg, M; Sauerbruch, T; Schepke, M; Trebicka, J | 1 |
| Carstens, J; Grønbaek, H; Larsen, HK; Pedersen, EB; Vilstrup, H | 1 |
| Angus, PW; Lubel, JS; McCaughan, GW; Warner, FJ | 1 |
| Hibi, T; Horikawa, H; Ishii, H; Kitamura, K; Kumagai, N; Kurita, S; Nakamoto, N; Saito, H; Tada, S; Toda, K; Tsunematsu, S | 1 |
| Fukui, H; Ikenaka, Y; Kaji, K; Kitade, M; Noguchi, R; Tsujimoto, T; Uemura, M; Yoshiji, H | 1 |
| Cao, G; Mastai, R; Mella, J; Muñoz, MC; Pereyra, L; Toblli, JE | 1 |
| Anan, A; Irie, M; Iwata, K; Sakisaka, S; Shakado, S; Sohda, T; Takeyama, Y | 1 |
| Hirano, Y; Ichikawa, S | 1 |
| Batenburg, PL | 1 |
| Cody, RJ | 1 |
| Hasumura, Y; Hattori, K; Takeuchi, J | 1 |
| Tang, ZD | 1 |
| Arroyo, V; Bosch, J; Mauri, M; Navarro-López, F; Ribera, F; Rodés, J | 1 |
| James, OF; Robson, V; Sellars, L; Shore, AC; Wilkinson, R | 1 |
| Anderson, GH; Anderson, T; Schroeder, ET; Streeten, DH | 1 |
| Martin, A; Naccarato, R; Sturniolo, GC | 1 |
| Elgeti, H; Luska, G | 1 |
| Wilkinson, SP; Williams, R | 2 |
| Brenner, BM; Skorecki, KL | 1 |
| Alavi, N; Bentzel, CJ; Lianos, EA; Tobin, M; Venuto, R | 1 |
| Craig, KJ; Cumming, AD; Hayes, PC; MacGilchrist, A | 1 |
| Eiskjaer, H; Jensen, JD; Jespersen, B; Mogensen, CE; Pedersen, EB; Sørensen, SS | 1 |
| Brock, A; Fogh-Andersen, N; Jespersen, B | 1 |
| Aramaki, T; Hayakawa, H; Nakamura, T; Ohki, K; Okumura, H; Seino, Y; Takano, T; Tsukamoto, H | 1 |
| Dillon, JF; Hayes, PC; Henderson, N; Jalan, R; O'Rourke, K; Redhead, DN; Thomas, HW; Williams, BC | 1 |
| Bouchier, IA; Dillon, JF; Hayes, PC; Neilson, JM; Nolan, J; Thomas, H; Williams, BC | 1 |
| Ford, NF; Langenbacher, KM; Lasseter, KC; Marino, MR; Raymond, RH | 1 |
| Arroyo, V; Clària, J; Ginès, P; Jiménez, W; Rivera, F; Rodés, J; Ros, J; Titos, E | 1 |
| Lebrec, D; Moreau, R | 1 |
| Boon, NA; Hayes, PC; Jalan, R; Masumori, S; Newby, DE; Webb, DJ | 1 |
| Casini-Raggi, V; Gentilini, P; La Villa, G; Romanelli, RG | 1 |
| Blendis, L; Collier, J; Girgrah, N; Liu, P; Wong, F | 1 |
| Hayes, PC; Helmy, A; Jalan, R; Newby, DE; Webb, DJ | 1 |
| Hayes, PC; Jalan, R | 1 |
| Jalan, R; Newby, DE | 1 |
| Burroughs, AK; Patch, D; Tang, AK; Vlachogiannakos, J | 1 |
| Heller, J; Malago, M; Molderings, GJ; Neef, M; Paschke, S; Sauerbruch, T; Schepke, M; Spengler, U; Thomas, J; Wolff, M | 1 |
| Border, WA; Noble, N | 1 |
| Du, R; Feng, H; Leng, X; Ma, F; Wang, B; Zhang, Z | 1 |
| Chang, FY; Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lee, TY; Lin, HC; Liu, RS; Yang, YY | 1 |
| Bernard, AG; Ginsburg, J; Lunzer, MR; Manghani, KK; Newman, SP; Sherlock, SP | 1 |
| Epstien, M | 1 |
| Epstein, M | 2 |
| Fiordalisi, HH; Mamianetti, A | 1 |
| Moult, P; Rosoff, L; Sherlock, S; Williams, H; Williams, J | 1 |
| Hata, T; Kumahara, Y; Mandai, T; Mikami, H; Nakamaru, M; Ogihara, T | 1 |
| Spech, HJ | 2 |
| Müller, G; Spech, HJ; Wernze, H | 1 |
| Arroyo, V; Bosch, Y; Mauri, M; Rivera, F; Rodes, J | 1 |
| Eguchi, T; Iyori, S; Kato, E; Kondo, K; Nakamura, R; Saito, I; Saruta, T | 1 |
| Anderson, GH; Goldman, SH; Schroeder, ET; Streeten, DH | 1 |
| Thiele, KG | 1 |
| Dürr, H; Klaus, D; Lange, H; Witzgall, H; Zehner, J | 1 |
| Chaudhury, RR; Chhuttani, PN; Dass, BK; Datta, DV; Saini, VK | 1 |
| Dodd, VN; Gordon, DB; Sachin, IN | 1 |
| Doi, K; Hata, T; Ichihara, K; Kumahara, Y; Ogihara, T; Yamamoto, T | 1 |
| Bernardi, M; Müller, G; Spech, HJ; Wellhöfer, G; Wernze, H; Wilkinson, SP | 1 |
| Castrucci, A; De Medici, L; Giacobini, E; Valenti, M | 1 |
| Carriére, S | 1 |
| Attali, JR; Bentata, M; Delzant, G; Krivitzky, A; Sebaoun, J; Weisselberg, C | 1 |
| Becker, CH; Engler, E; Herrmann, HJ; Matthias, D | 1 |
| Acquaviva, G; Arzilli, F; Salvetti, A; Sassano, P | 1 |
| Kondo, K | 1 |
| Donker, AJ; Hackeng, WH; Meuwissen, SG; van Vliet, AA | 1 |
| Firth, JD; Gove, CD; Panos, MZ; Raine, AE; Williams, R | 1 |
| Jiang, HQ; Liu, HQ; Yao, XX | 1 |
| Ando, M | 1 |
| MacGilchrist, AJ; Reid, JL; Sumner, D | 1 |
| Bessent, RG; Bradnam, MS; Fenner, J; Goldberg, JA; Kerr, DJ; McArdle, CS; McKee, RF; McKillop, JH | 1 |
| Brunner, HR; Nüssberger, J; Waeber, B | 1 |
| Bernardi, M; De Palma, R; Gasbarrini, G; Santini, C; Servadei, D; Trevisani, F | 1 |
| Mott, V; Sellars, L; Shore, AC; Wilkinson, R | 1 |
| Serebrovskaia, IuA; Uchitel', IA | 1 |
| Kiseleva, ZM; Serebrovskaia, IuA; Uchitel', IA | 1 |
| Brown, JJ; Davies, DL; Lever, AF; Robertson, JI; Tree, M | 1 |
| Jahn, H; Kuntzmann, F; Kurtz, T; Réville, P; Stahl, J | 2 |
| Fisher, ER; Hellstrom, HR | 1 |
| Galow, W; Hirsch, HH | 2 |
| Fujimoto, S; Hiwada, K; Kokubu, T; Sanga, H; Ueda, E; Yamamura, Y | 1 |
| Baldus, WP; Maher, FT; McCloy, RM; Summerskill, WH | 1 |
| Doyle, AE; Louis, WJ | 1 |
| Agrest, A; Finkielman, S; Massani, ZM; Paladini, AC; Worcel, M | 1 |
| Gould, AB; Kahn, JR; Skeggs, LT | 1 |
| Lucchelli, PD; Natangelo, R; Santambrogio, S | 1 |
| Grütte, E; Schröder, R; Schüren, KP | 1 |
| Blaise, BH; Düsterdieck, G; Jahnecke, J; Kobayashi, T; Krück, F; Lommer, D; Schieffer, H; Wolff, HP | 1 |
| Ayers, CR | 1 |
| Gabuzda, GJ; Sancetta, SM; Schroeder, ET; Shear, L | 1 |
| Berkmen, R | 2 |
| Heizmann, A; Klaus, D; Sadowski, P | 1 |
| Abdel Hamid, H; el-Ebrashy, N; Higazi, AM; Khalifa, K; Safourie, S | 1 |
| Wolff, HP | 1 |
| Jahn, H; Kuntzmann, F; Kurtz, T; Reville, P; Stahl, J; Vassaux, C | 1 |
| Hammel, EC; Lubash, GD; Mearles, RJ | 1 |
| Ferris, TF; Gorden, P | 1 |
| Bános, C; Borbély, L; Radó, JP; Takó, J | 1 |
| Altman, KA | 1 |
| McGiff, JC | 1 |
| Arai, J; Asano, S; Higashi, F; Ozawa, Y; Saruta, T | 1 |
| Imai, M; Sokabe, H | 1 |
| Boucher, R; de Champlain, J; Genest, J; Koiw, E; Veyrat, R | 1 |
| Hirasawa, K | 1 |
| Ajzen, H; Andrade, U; Cipullo, JP; Gelman, A; Ramos, OL; Stella, SR; Sustovich, DR | 1 |
| Ajzen, H; Andrade, U; Cipullo, JP; Ramos, OL; Sustovich, DR | 1 |
| Thomsen, AC | 1 |
| Heizmann, A; Klaus, D | 1 |
| Gliedman, ML; Mullane, JF | 1 |
| Borbély, L; Kalcseva, S; Radó, J; Szende, L; Takó, J | 1 |
| Mach, RS; Muller, AF; Veyrat, R | 1 |
| Bourel, M; Chauvel, A; Lenoir, P; Pawlotsky, Y; Pirot, D; Simon, M | 1 |
| Janukowicz-Lorenz, H; Lorenz, J; Skóra, K | 1 |
| Baldus, WP; Barnardo, DE; Strong, CG | 1 |
| Oelkers, W; von Goldacker, IU | 1 |
| Bisht, DB; Janaki, M | 1 |
| Wachowiak, A | 1 |
| Loyke, HF | 1 |
| Baldus, WP; Barnardo, DE; Strong, CG; Summerskill, WH | 1 |
| Dauda, G; Dévényi, I; Szabó, J; Szokoly, V | 1 |
| Eich, RH; Gabuzda, GJ; Gould, AB; Schroeder, ET; Smulyan, H | 1 |
| Buligescu, L; Runcan, V; Tutunaru, M | 1 |
| Schmid, E | 1 |
| Kato, E; Nomoto, Y | 1 |
| Ventura, E; Zeneroli, ML | 1 |
| Kondo, T | 1 |
| Dabels, J; Kochan, E; Sievers, P; Wendel, H | 1 |
| Michel, H; Seki, A; Wernze, H | 1 |
| Isakova, ZS; Loginov, AS; Serebrovskaia, IuA; Uchitel', IA | 1 |
| Jesse, R; Schneider, KW; Seki, A; Wernze, H | 1 |
| Bucur, G; Galea, G; Varlas, A | 1 |
| Araki, Y; Miyazaki, T; Mizukoshi, H | 1 |
| Baldus, WP | 1 |
| Breuer, H; Kaulhausen, H; Pfeiffer, P | 1 |
| Cutler, RE; Fleet, WP; Forrey, AW; Gutman, RA | 1 |
| Bailleux, A; Belet, JL; Cadudal, JL; Cottin, S; Miniconi, P; Talmant, JC | 1 |
| Berkowitz, HD; Galvin, CC; Miller, LD | 1 |
| Cohn, JN; Guiha, NH; Lekagul, O; Limas, CJ | 1 |
| Conti, CR; Horvath, JS; Mitch, WE; Moore, MA; Russell, RP; Walker, WG | 1 |
| Hidaka, H; Ito, T; Kato, T; Yoshitoski, Y | 1 |
| Kondo, K; Matsuki, S; Nakamura, R; Saito, I; Saruta, T | 1 |
| Arbeiter, G; Meyer-Burg, J | 1 |
40 review(s) available for angiotensin ii and Liver Cirrhosis
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Atrial Fibrillation; Blood Coagulation; Capillary Permeability; Cardiomyopathies; COVID-19; Cytokine Release Syndrome; Cytokines; Endothelium, Vascular; Fibroblasts; Fibrosis; Humans; Liver Cirrhosis; Myocarditis; Receptors, Coronavirus; Renin-Angiotensin System; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Thrombosis; Virus Internalization | 2020 |
Renin angiotensin system in liver diseases: Friend or foe?
Topics: Angiotensin II; Animals; Cell Proliferation; Fibrosis; Hemodynamics; Hepatorenal Syndrome; Humans; Inflammation; Liver; Liver Cirrhosis; Liver Diseases; Mice; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2017 |
Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Humans; Hypertension, Portal; Liver Cirrhosis; Peptide Fragments; Renin-Angiotensin System | 2018 |
Role of NADPH oxidases in liver fibrosis.
Topics: Angiotensin II; Hepatic Stellate Cells; Humans; Liver Cirrhosis; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species; Signal Transduction | 2014 |
Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Humans; Hypertension, Portal; Kallikreins; Kinins; Liver; Liver Cirrhosis; Liver Diseases; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2008 |
Cytokines and renin-angiotensin system signaling in hepatic fibrosis.
Topics: Angiotensin II; Animals; Collagen; Cytokines; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Renin-Angiotensin System; Signal Transduction | 2008 |
Current and future anti-fibrotic therapies for chronic liver disease.
Topics: Angiotensin II; Chronic Disease; Colchicine; Collagen; Extracellular Matrix; Hepatic Stellate Cells; Humans; Interferon-gamma; Ligands; Liver Cirrhosis; PPAR gamma; Pyridones | 2008 |
Renin-angiotensin system in the pathogenesis of liver fibrosis.
Topics: Angiotensin II; Animals; Humans; Liver Cirrhosis; Peptide Fragments; Renin-Angiotensin System | 2009 |
Antifibrotic therapies: will we ever get there?
Topics: Angiotensin II; Caspase Inhibitors; Humans; Interferon-alpha; Interferon-gamma; Liver Cirrhosis; PPAR gamma | 2010 |
NADPH oxidase mediated oxidative stress in hepatic fibrogenesis.
Topics: Angiotensin II; Hepatic Stellate Cells; Humans; Liver Cirrhosis; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species | 2011 |
Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Hepatorenal Syndrome; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Splanchnic Circulation; Vasodilation | 2012 |
The role of angiotensin II in nonalcoholic steatohepatitis.
Topics: Angiotensin II; Animals; Chronic Disease; Fatty Liver; Humans; Insulin Resistance; Liver Cirrhosis; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Renin-Angiotensin System; Signal Transduction | 2013 |
[Renin angiotensin system and liver fibrosis or cirrhosis].
Topics: Angiotensin II; Ascites; Humans; Hypertension, Portal; Liver Cirrhosis; Renin-Angiotensin System | 2003 |
[Mitogenic action of endothelin on fibroblasts].
Topics: Angiotensin II; Animals; Cell Division; Collagen; Endothelin-1; Extracellular Matrix; Fibroblast Growth Factor 2; Fibroblasts; Glomerulosclerosis, Focal Segmental; Humans; Hypertension; Liver Cirrhosis; Myoblasts, Cardiac; Myocardial Infarction; Pulmonary Fibrosis; Receptors, Endothelin; Transforming Growth Factor beta; Ventricular Remodeling | 2004 |
Liver fibrosis.
Topics: Angiotensin II; Animals; Humans; Hypertension, Portal; Leptin; Liver Cirrhosis; Liver Failure; Transforming Growth Factor beta | 2005 |
Liver fibrosis: a balance of ACEs?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Liver Cirrhosis; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2007 |
Renin-angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Carcinoma, Hepatocellular; Humans; Liver Cirrhosis; Liver Neoplasms; Neovascularization, Physiologic; Renin-Angiotensin System; Vascular Endothelial Growth Factor A | 2007 |
[Hepatorenal syndrome].
Topics: Angiotensin II; Endotoxins; Hemodynamics; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Liver Transplantation; Neurotransmitter Agents; Peritoneal Dialysis; Peritoneovenous Shunt; Portasystemic Shunt, Surgical; Renal Dialysis; Renin; Syndrome | 1981 |
Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Captopril; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertension, Pulmonary; Kinetics; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Renin; Renin-Angiotensin System; Teprotide | 1984 |
[Angiographic methods for the diagnosis and therapy of liver diseases].
Topics: Angiography; Angiotensin II; Bradykinin; Hepatic Artery; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Portacaval Shunt, Surgical; Portal Vein; Portography; Venous Pressure | 1980 |
Body fluid homeostasis in congestive heart failure and cirrhosis with ascites.
Topics: Aldosterone; Angiotensin II; Blood Volume; Body Fluids; Body Water; Cardiac Volume; Heart Failure; Homeostasis; Humans; Kidney; Kinins; Liver Cirrhosis; Prostaglandins; Renin; Sodium | 1982 |
Transduction of antinatriuretic signals in renal proximal tubular cells in cirrhosis: introduction to novel approaches to the treatment of sodium retention.
Topics: Adrenergic Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Humans; Kidney Tubules, Proximal; Liver Cirrhosis; Losartan; Models, Biological; Natriuresis; Norepinephrine; Signal Transduction; Sodium; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase | 1998 |
Hepatorenal syndrome and its treatment today.
Topics: Angiotensin II; Ascites; Diuretics; Hemodynamics; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation | 1999 |
Vasoactive agents in intrahepatic portal hypertension and fibrogenesis: implications for therapy.
Topics: Angiotensin II; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Vasoconstrictor Agents | 2000 |
Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Chronic Disease; Glomerular Filtration Rate; Humans; Hypertension, Portal; Liver Cirrhosis; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Sodium | 2001 |
Maximizing hemodynamic-independent effects of angiotensin II antagonists in fibrotic diseases.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Fibrosis; Humans; Kidney Diseases; Liver Cirrhosis; Pulmonary Fibrosis; Renin-Angiotensin System; Transforming Growth Factor beta | 2001 |
Renal failure in cirrhosis: current views and speculations.
Topics: Angiotensin II; Animals; Diuretics; Dogs; Endotoxins; Humans; Kidney; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Tubules; Liver Cirrhosis; Renin; Spleen; Uremia; Vasoconstriction | 1977 |
Deranged renal function in liver disease.
Topics: Angiotensin II; Diet, Sodium-Restricted; Furosemide; Humans; Hyperaldosteronism; Kidney; Kidney Diseases; Liver Cirrhosis; Liver Diseases; Oliguria; Prognosis; Renin; Sodium; Syndrome | 1977 |
Renal effects of head-out water immersion in man: implications for an understanding of volume homeostasis.
Topics: Acid-Base Equilibrium; Aldosterone; Angiotensin II; Animals; Blood Volume; Catecholamines; Diuresis; Dogs; Humans; Immersion; Kidney; Kidney Diseases; Liver Cirrhosis; Natriuresis; Parathyroid Hormone; Phosphates; Potassium; Primates; Prostaglandins; Renin; Temperature; Vasopressins; Water-Electrolyte Balance | 1978 |
Factors affecting renal cortical blood flow. A review.
Topics: Acetylcholine; Acute Kidney Injury; Angiotensin II; Animals; Bradykinin; Diuretics; Dogs; Dopamine; Electric Stimulation; Epinephrine; Heart Failure; Hemorrhage; Humans; Hypotension; Isoproterenol; Kidney Cortex; Kidney Transplantation; Liver Cirrhosis; Norepinephrine; Oxytocin; Prostaglandins; Regional Blood Flow; Transplantation, Homologous; Ureter; Vasomotor System; Vasopressins; Vena Cava, Inferior; Water-Electrolyte Balance | 1975 |
Clinical applications of antimineralocorticoids.
Topics: Aldosterone; Angiotensin II; Ascites; Glucose; Heart Failure; Humans; Hypertension; Liver Cirrhosis; Mineralocorticoids; Renin; Water-Electrolyte Balance | 1988 |
Aldosterone in clinical medicine.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Heart Failure; Humans; Hyperaldosteronism; Hypertension, Malignant; Hypokalemia; Hypotension; Liver Cirrhosis; Metabolic Clearance Rate; Natriuresis; Nephrotic Syndrome; Posture; Renal Artery Obstruction; Renin; Secretory Rate | 1968 |
Hepatorenal syndrome. A review.
Topics: Angiotensin II; Body Fluids; Central Nervous System Diseases; Humans; Kidney; Kidney Diseases; Liver; Liver Cirrhosis; Liver Diseases; Renin; Urea; Vascular Resistance | 1968 |
Tissue hormones: angiotensin, bradykinin and the regulation of regional blood flows.
Topics: Aldosterone; Angiotensin II; Animals; Autonomic Nervous System; Bradykinin; Calcium; Catecholamines; Dogs; Female; Glomerular Filtration Rate; Humans; Hypertension; Ischemia; Kallikreins; Kidney; Liver Cirrhosis; Neurosecretion; Regional Blood Flow; Renin; Sodium Chloride; Uterus | 1968 |
[Peptide metabolism in liver insufficiency].
Topics: Aldosterone; Angiotensin II; Animals; Aprotinin; Gastric Juice; Gastrins; Hepatitis; Histamine; Humans; Hydroxyindoleacetic Acid; Kinins; Liver Cirrhosis; Liver Diseases; Peptides; Renin; Serotonin | 1969 |
[Liver cirrhosis].
Topics: Aldosterone; Angiotensin II; Ascites; Humans; Juxtaglomerular Apparatus; Kidney; Liver; Liver Cirrhosis; Renin; Sodium; Vasopressins | 1971 |
[The renin-angiotensin system in patients with cirrhosis of the liver].
Topics: Angiotensin II; Ascites; Chronic Disease; Endopeptidases; Hepatitis A; Humans; Hypertension; Liver Cirrhosis; Renin | 1971 |
[Abnormalities of sodium and water metabolism with special reference to hypertensive diseases].
Topics: Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hypertension, Renal; Kidney Failure, Chronic; Liver Cirrhosis; Natriuresis; Renin; Sodium; Water; Water-Electrolyte Balance | 1972 |
Renal failure in advanced liver disease.
Topics: Acute Kidney Injury; Aldosterone; Angiotensin II; Ascites; Body Water; Hemodynamics; Humans; Kidney; Kidney Function Tests; Kidney Tubules; Liver; Liver Cirrhosis; Liver Diseases; Prognosis; Regional Blood Flow; Renin; Sodium; Uremia | 1972 |
9 trial(s) available for angiotensin ii and Liver Cirrhosis
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Renal effects of NO-inhibition in patients with cirrhosis vs. healthy controls: a randomized placebo-controlled crossover study.
Topics: Angiotensin II; Cross-Over Studies; Denmark; Edetic Acid; Glomerular Filtration Rate; Hemodynamics; Humans; Iodine Radioisotopes; Kidney; Liver Cirrhosis; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Renal Plasma Flow; Renin | 2014 |
Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.
Topics: Angiotensin II; Ascites; Enzyme Inhibitors; Female; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Renin; Sodium; Water | 2003 |
Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Esophageal and Gastric Varices; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis; Losartan; Male; Middle Aged; Portal Vein; Propranolol | 2003 |
[Influence of Na supplement and limitation on blood PRA, AII, ALD and renal function in patients with liver cirrhosis].
Topics: Adult; Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Female; Humans; Kidney; Kidney Function Tests; Liver Cirrhosis; Male; Middle Aged; Renin; Sodium | 2004 |
Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention.
Topics: Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Cross-Over Studies; Diuretics; Female; Humans; Kidney Tubules, Proximal; Liver Cirrhosis; Male; Middle Aged; Natriuresis; Peptide Fragments; Renin; Sodium | 2007 |
Pharmacokinetics and pharmacodynamics of irbesartan in patients with hepatic cirrhosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Female; Humans; Irbesartan; Liver Cirrhosis; Male; Middle Aged; Renin; Tetrazoles | 1998 |
Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
Topics: Angiotensin II; Diuresis; Furosemide; Glomerular Filtration Rate; Humans; Liver Cirrhosis; Male; Middle Aged; Muzolimine; Potassium; Pyrazoles; Renin; Sodium; Time Factors | 1985 |
[Methods for the determination of renin activity in plasma].
Topics: Angiotensin II; Animals; Biological Assay; Blood Chemical Analysis; Blood Pressure; Chemistry, Clinical; Clinical Trials as Topic; Female; Hydrogen-Ion Concentration; Liver Cirrhosis; Methods; Rats; Renin | 1968 |
190 other study(ies) available for angiotensin ii and Liver Cirrhosis
| Article | Year |
|---|---|
[Study of the negative regulation of transforming growth factor beta type II receptor to inhibit the occurrence and development of liver fibrosis with miR-217].
Topics: Actins; Angiotensin II; Animals; Carbon Tetrachloride; Collagen Type I; Hepatic Stellate Cells; Liver Cirrhosis; Mice; MicroRNAs; Receptor, Transforming Growth Factor-beta Type II; S100 Calcium-Binding Protein A4; Transforming Growth Factor beta1 | 2022 |
Olmesartan Improves Hepatic Sinusoidal Remodeling in Mice with Carbon Tetrachloride-Induced Liver Fibrosis.
Topics: Angiotensin II; Animals; Carbon Tetrachloride; Collagen; Imidazoles; Interleukin-10; Liver Cirrhosis; Mice; Neovascularization, Pathologic; Tetrazoles; Vascular Endothelial Growth Factor A | 2022 |
The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Chymases; Humans; Hypertension, Portal; Inflammation; Liver Cirrhosis; Peptidyl-Dipeptidase A; Prospective Studies; Renin-Angiotensin System; Vascular Diseases | 2023 |
Angiotensin II type-2 receptor attenuates liver fibrosis progression by suppressing IRE1α-XBP1 pathway.
Topics: Adult; Angiotensin II; Animals; Endoplasmic Reticulum Stress; Endoribonucleases; Humans; Liver Cirrhosis; Mice; Protein Serine-Threonine Kinases; Signal Transduction; X-Box Binding Protein 1 | 2024 |
AVE 0991 Attenuates Pyroptosis and Liver Damage after Heatstroke by Inhibiting the ROS-NLRP3 Inflammatory Signalling Pathway.
Topics: Angiotensin I; Angiotensin II; Animals; Biomarkers; Heat Stroke; Hepatocytes; Humans; Imidazoles; Inflammasomes; Inflammation; Interleukin-1beta; Liver; Liver Cirrhosis; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Peptide Fragments; Prospective Studies; Pyroptosis; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction | 2019 |
Angiotensin II in Decompensated Cirrhosis Complicated by Septic Shock.
Topics: Angiotensin II; Humans; Liver Cirrhosis; Male; Middle Aged; Shock, Septic; Treatment Outcome; Vasoconstrictor Agents | 2020 |
Carvedilol Inhibits Angiotensin II-Induced Proliferation and Contraction in Hepatic Stellate Cells through the RhoA/Rho-Kinase Pathway.
Topics: Angiotensin II; Animals; Carbon Tetrachloride Poisoning; Carvedilol; Cell Proliferation; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Male; Mice; Receptor, Angiotensin, Type 1; rho-Associated Kinases; rhoA GTP-Binding Protein | 2019 |
Levistilide A reverses rat hepatic fibrosis by suppressing angiotensin II‑induced hepatic stellate cells activation.
Topics: Actins; Angiotensin II; Animals; Carbon Tetrachloride; Cell Proliferation; Cell Survival; Cells, Cultured; Disease Models, Animal; Hepatic Stellate Cells; Heterocyclic Compounds, Bridged-Ring; Liver Cirrhosis; Male; Rats; Receptor, Angiotensin, Type 1; Signal Transduction; Up-Regulation | 2020 |
Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Apoptosis; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; Disease Progression; Disease Susceptibility; Humans; Liver Cirrhosis; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Preliminary Data; SARS-CoV-2; Up-Regulation | 2020 |
ASK1 Enhances Angiotensin II-Induced Liver Fibrosis
Topics: Angiotensin II; Cell Line; Cell Survival; Coculture Techniques; Culture Media, Conditioned; Cytokines; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Exosomes; Humans; Inflammation; Liver Cirrhosis; MAP Kinase Kinase Kinase 5; Microscopy, Electron; Microscopy, Fluorescence; Reactive Oxygen Species | 2020 |
Internal dysregulation of the renin system in patients with stable liver cirrhosis.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Case-Control Studies; Creatinine; Female; Glomerular Filtration Rate; Heart Rate; Hemodynamics; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Renin-Angiotensin System | 2017 |
BML-111 equilibrated ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis to protect hepatic fibrosis in rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Down-Regulation; Heptanoic Acids; Liver Cirrhosis; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Up-Regulation | 2017 |
Periostin cross‑reacts with the renin‑angiotensin system during liver fibrosis development.
Topics: Angiotensin II; Animals; Cell Adhesion Molecules; Collagen Type I; Collagen Type I, alpha 1 Chain; Gene Expression Regulation; Hepatic Stellate Cells; Humans; Liver; Liver Cirrhosis; Losartan; Rats; Renin-Angiotensin System; Signal Transduction; Transforming Growth Factor beta1 | 2017 |
A novel hamster nonalcoholic steatohepatitis model induced by a high-fat and high-cholesterol diet.
Topics: Angiotensin II; Animals; Body Weight; Cholesterol, Dietary; Chymases; Cricetinae; Diet, High-Fat; Disease Models, Animal; Liver; Liver Cirrhosis; Male; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Organ Size; Transforming Growth Factor beta | 2018 |
Serum levels of angiotensin converting enzyme as a biomarker of liver fibrosis.
Topics: Angiotensin II; Biomarkers; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2017 |
Effects of angiotensin-(1-7) and angiotensin II on vascular tone in human cirrhotic splanchnic vessels.
Topics: Angiotensin I; Angiotensin II; Female; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Omentum; Peptide Fragments; Renin-Angiotensin System; Vasodilation | 2018 |
MicroRNA‑219 overexpression serves a protective role during liver fibrosis by targeting tumor growth factor β receptor 2.
Topics: Angiotensin II; Cell Proliferation; Gene Expression Regulation, Neoplastic; Hepatic Stellate Cells; Humans; Liver Cirrhosis; MicroRNAs; Receptor, Transforming Growth Factor-beta Type II; Signal Transduction | 2019 |
Calpain 9 as a therapeutic target in TGFβ-induced mesenchymal transition and fibrosis.
Topics: Angiotensin II; Animals; Bleomycin; Calcium-Binding Proteins; Calpain; Carbon Tetrachloride; Cell Line; Dogs; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Isoenzymes; Liver Cirrhosis; Male; Mice, Inbred C57BL; Molecular Targeted Therapy; Myocardium; Protein Biosynthesis; Protein Multimerization; RNA Stability; Signal Transduction; Transforming Growth Factor beta | 2019 |
Targeting AngII/AT1R signaling pathway by perindopril inhibits ongoing liver fibrosis in rat.
Topics: Angiotensin II; Animals; Liver Cirrhosis; Male; Perindopril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Thioacetamide | 2019 |
Up-regulation of components of the renin-angiotensin system in liver fibrosis in the rat induced by CCL₄.
Topics: Angiotensin I; Angiotensin II; Animals; Blotting, Western; Carbon Tetrachloride; Gene Expression Regulation, Enzymologic; Liver Cirrhosis; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Random Allocation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Renin-Angiotensin System; RNA; Statistics, Nonparametric; Up-Regulation | 2013 |
Angiotensin II induces endothelin-1 expression in human hepatic stellate cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Cells, Cultured; Endothelin-1; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Renin-Angiotensin System | 2013 |
Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
Topics: Angiotensin II; Animals; Anticarcinogenic Agents; Catechin; Fatty Liver; Gene Expression; Hypertension; Interleukin-6; Lipid Peroxidation; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Peptidyl-Dipeptidase A; Precancerous Conditions; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Tumor Necrosis Factor-alpha | 2014 |
Angiotensin II facilitates fibrogenic effect of TGF-β1 through enhancing the down-regulation of BAMBI caused by LPS: a new pro-fibrotic mechanism of angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cell Line; Collagen Type I; Down-Regulation; Hepatic Stellate Cells; Lipopolysaccharides; Liver; Liver Cirrhosis; Male; Membrane Proteins; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Time Factors; Toll-Like Receptor 4; Transforming Growth Factor beta1; Up-Regulation | 2013 |
A disintegrin and metalloproteinase 17 (ADAM17) mediates epidermal growth factor receptor transactivation by angiotensin II on hepatic stellate cells.
Topics: ADAM Proteins; ADAM17 Protein; Amphiregulin; Angiotensin II; Blotting, Western; Cell Line; Cell Proliferation; Dipeptides; Disease Progression; EGF Family of Proteins; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Gene Silencing; Glycoproteins; Hepatic Stellate Cells; Humans; Hydroxamic Acids; Intercellular Signaling Peptides and Proteins; Liver Cirrhosis | 2014 |
Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.
Topics: Angiotensin II; Animals; Bile Ducts; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Hepatic Stellate Cells; Humans; Janus Kinase 2; Ligation; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Myofibroblasts; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; Thioacetamide | 2014 |
Bone Marrow Stromal Cells Inhibit the Activation of Liver Cirrhotic Fat-Storing Cells via Adrenomedullin Secretion.
Topics: Actins; Adrenomedullin; Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; Coculture Techniques; Collagen Type I; Hepatic Stellate Cells; Lipid Metabolism; Liver; Liver Cirrhosis; Mesenchymal Stem Cells; NADPH Oxidases; Paracrine Communication; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Platelet-Derived Growth Factor beta; RNA Interference; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Transfection | 2015 |
The association of renin-angiotensin system genes with the progression of hepatocellular carcinoma.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Antigens, CD34; Biomarkers, Tumor; Carcinoma, Hepatocellular; Case-Control Studies; Gene Expression Regulation, Neoplastic; Humans; Liver Cirrhosis; Liver Neoplasms; Peptide Fragments; Peptidyl-Dipeptidase A; Prognosis; Reference Values; Renin-Angiotensin System; Vascular Endothelial Growth Factor A | 2015 |
ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cytokines; Dependovirus; Disease Models, Animal; Enzyme Activation; Gene Expression; Genetic Therapy; Genetic Vectors; Hepatic Stellate Cells; Inflammation Mediators; Injections, Intraperitoneal; Lipid Peroxidation; Liver Cirrhosis; Liver Function Tests; Male; MAP Kinase Signaling System; Methoxamine; Mice; NADPH Oxidases; Neovascularization, Pathologic; Organ Specificity; Oxidative Stress; Peptidyl-Dipeptidase A; RNA, Messenger | 2015 |
Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
Topics: Administration, Intravenous; Aged; Albumins; Aldosterone; Angiotensin II; Ascites; Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Norepinephrine; Odds Ratio; Paracentesis; Pilot Projects; Portasystemic Shunt, Transjugular Intrahepatic; Renin; Risk Factors | 2016 |
Angiotensin(1-7) attenuated Angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H2O2-activated NLRP3 inflammasome/IL-1β/Smad circuit.
Topics: Angiotensin I; Angiotensin II; Animals; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Epithelial-Mesenchymal Transition; Gene Expression; Hepatocytes; Humans; Hydrogen Peroxide; Inflammasomes; Interleukin-1beta; Liver Cirrhosis; Male; Mice; NADPH Oxidase 4; NLR Family, Pyrin Domain-Containing 3 Protein; Peptide Fragments; Rats, Wistar; Signal Transduction; Smad Proteins | 2016 |
MicroRNA-21 Mediates Angiotensin II-Induced Liver Fibrosis by Activating NLRP3 Inflammasome/IL-1β Axis via Targeting Smad7 and Spry1.
Topics: Angiotensin II; Animals; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; Hepatic Stellate Cells; Humans; Inflammasomes; Interleukin-1beta; Liver Cirrhosis; Membrane Proteins; MicroRNAs; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphoproteins; Rats; Smad7 Protein | 2017 |
Swertiamarin Attenuates Experimental Rat Hepatic Fibrosis by Suppressing Angiotensin II-Angiotensin Type 1 Receptor-Extracellular Signal-Regulated Kinase Signaling.
Topics: Angiotensin II; Animals; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Hepatic Stellate Cells; Iridoid Glucosides; Liver Cirrhosis; Pyrones; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction | 2016 |
Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data.
Topics: Angiotensin II; Animals; Chymases; Humans; Immunohistochemistry; Kidney; Kidney Function Tests; Liver; Liver Cirrhosis; Liver Function Tests; Male; Portal Pressure; Rats; Rats, Wistar | 2016 |
Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin I; Angiotensin II; Angiotensins; Cross-Sectional Studies; Female; Hemodynamics; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Peptide Fragments; Portal Vein; Propranolol; Renin; Renin-Angiotensin System; Splanchnic Circulation | 2008 |
Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis.
Topics: Analysis of Variance; Angiotensin II; Animals; Blotting, Western; Cell Survival; Cells, Cultured; Disease Models, Animal; Enzyme Activation; Hepatocytes; Humans; Immunohistochemistry; Liver Cirrhosis; Male; Microscopy, Confocal; NF-kappa B; Phosphorylation; Probability; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Transfer, Ser; Sensitivity and Specificity; Signal Transduction; Transcription Factor RelA | 2009 |
Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.
Topics: Actins; Adult; Angiotensin I; Angiotensin II; Animals; Bile Ducts; Cells, Cultured; Drug Evaluation, Preclinical; Female; Hepatitis C, Chronic; Humans; Hydroxyproline; Liver; Liver Cirrhosis; Liver Cirrhosis, Experimental; Male; Middle Aged; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; RNA, Messenger; Up-Regulation | 2009 |
ANG II-AT1 receptor pathway is involved in the anti-fibrotic effect of beta-elemene.
Topics: Angiotensin II; Animals; Down-Regulation; Liver Cirrhosis; Male; Random Allocation; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Sesquiterpenes | 2009 |
Unraveling the spider web of hepatic stellate cell apoptosis.
Topics: Angiotensin II; Apoptosis; Cell Differentiation; Fibroblasts; Hepatic Stellate Cells; Humans; I-kappa B Kinase; Liver Cirrhosis; Phosphorylation; Risk Assessment; Sensitivity and Specificity | 2009 |
Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis.
Topics: Angiotensin I; Angiotensin II; Animals; Cross-Sectional Studies; Female; Hemodynamics; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Peptide Fragments; Renin-Angiotensin System; Splanchnic Circulation | 2009 |
Vascular hyporesponsiveness to angiotensin II in rats with CCl(4)-induced liver cirrhosis.
Topics: Angiotensin II; Animals; Aorta; Blotting, Western; Carbon Tetrachloride; Hypertension, Portal; Liver Cirrhosis; Male; Rats; Receptor, Angiotensin, Type 1; Vasodilation | 2009 |
Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Carbon Tetrachloride Poisoning; Extracellular Signal-Regulated MAP Kinases; Gene Deletion; Hepatic Stellate Cells; Ligation; Liver Cirrhosis; Mice; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Recombinant Proteins; Renin-Angiotensin System | 2009 |
[Expression, purification and polyclonal antibody preparation for a novel gene BC097361].
Topics: Angiotensin II; Animals; Antibodies; Antibody Specificity; Blotting, Western; Cloning, Molecular; Escherichia coli; Gene Expression; Genetic Vectors; Liver Cirrhosis; Male; Plasmids; Rabbits; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition.
Topics: Angiotensin II; Animals; Anthracenes; Carrier Proteins; Cell Division; Cells, Cultured; Disease Models, Animal; Fatty Liver; Fibroblasts; Hepatic Stellate Cells; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Mutant Strains; Mitogen-Activated Protein Kinase 9; Phosphorylation; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Transforming Growth Factor beta | 2010 |
CD38-mediated Ca2+ signaling contributes to angiotensin II-induced activation of hepatic stellate cells: attenuation of hepatic fibrosis by CD38 ablation.
Topics: ADP-ribosyl Cyclase 1; Angiotensin II; Animals; Calcium; Calcium Signaling; Cell Proliferation; Collagen Type I; Cyclic ADP-Ribose; Extracellular Matrix Proteins; Gene Deletion; Hepatic Stellate Cells; Inositol 1,4,5-Trisphosphate; Intracellular Space; Liver Cirrhosis; Mice; Models, Biological; NADP | 2010 |
Down-regulation of angiotensin II by shRNA reduces collagen synthesis in hepatic stellate cells.
Topics: Angiotensin II; Animals; Collagen; Down-Regulation; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Rats; RNA Interference; RNA, Small Interfering; Transforming Growth Factor beta1 | 2010 |
Renin-angiotensin system activation in congenital hepatic fibrosis in the PCK rat model of autosomal recessive polycystic kidney disease.
Topics: Angiotensin II; Animals; Collagen; Disease Models, Animal; Disease Progression; Gene Expression; Liver; Liver Cirrhosis; Male; Peptidyl-Dipeptidase A; Polycystic Kidney, Autosomal Recessive; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Transforming Growth Factor beta | 2010 |
Apelin mediates the induction of profibrogenic genes in human hepatic stellate cells.
Topics: Analysis of Variance; Angiotensin II; Animals; Apelin; Blotting, Western; Cell Line; Cells, Cultured; Collagen Type I; Endothelin-1; Fluorescent Antibody Technique; Gene Expression; Hepatic Stellate Cells; Humans; Intercellular Signaling Peptides and Proteins; Liver; Liver Cirrhosis; Male; Middle Aged; Rats; Rats, Wistar; Receptor, Platelet-Derived Growth Factor beta; Receptors, Transforming Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric | 2010 |
Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis.
Topics: Angiotensin II; Animals; Collagen; Extracellular Matrix; Gene Deletion; Humans; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Plasminogen Activator Inhibitor 1 | 2011 |
Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence.
Topics: Angiotensin II; Animals; Antioxidants; Azetidinecarboxylic Acid; Calcium; Calcium Channel Blockers; Carbon Tetrachloride; Cell Line; Cell Survival; Collagen Type I; Collagen Type I, alpha 1 Chain; Dihydropyridines; Disease Models, Animal; Gene Expression Regulation; Humans; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Reactive Oxygen Species; RNA, Messenger; Thioacetamide; Transforming Growth Factor beta1 | 2012 |
Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.
Topics: Angiotensin II; Animals; Enzyme Inhibitors; Gene Expression; Hepatic Stellate Cells; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 4; NADPH Oxidases; Neuropeptides; Pyrazoles; Pyrazolones; Pyridines; Pyridones; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; Reactive Oxygen Species; RNA, Messenger; Superoxide Dismutase; Superoxide Dismutase-1; Up-Regulation | 2012 |
Aliskiren attenuates chronic carbon tetrachloride-induced liver injury in mice.
Topics: Amides; Angiotensin II; Animals; Antihypertensive Agents; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury, Chronic; Drug Interactions; Fumarates; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Random Allocation; Renin | 2012 |
Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Blotting, Western; Endothelium, Vascular; In Situ Hybridization; Liver; Liver Circulation; Liver Cirrhosis; Male; Methoxamine; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Vasoconstrictor Agents | 2013 |
Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Communication; Disease Models, Animal; Disease Progression; DNA Primers; Dose-Response Relationship, Drug; Fatty Liver; Gene Expression; Hepatic Stellate Cells; Liver Cirrhosis; Losartan; Male; NF-kappa B; Non-alcoholic Fatty Liver Disease; Rats; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Toll-Like Receptor 4; Transforming Growth Factor beta | 2013 |
Nitric oxide mediates the reduced vasoconstrictor response to angiotensin II in patients with preascitic cirrhosis.
Topics: Angiotensin II; Ascites; Case-Control Studies; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Forearm; Humans; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Regional Blood Flow; Vasoconstriction; Vasoconstrictor Agents | 2003 |
Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load.
Topics: Adult; Aldosterone; Angiotensin II; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Atrial Natriuretic Factor; Chronic Disease; Drinking; Female; Heart Failure; Humans; Liver Cirrhosis; Male; Middle Aged; Natriuretic Peptide, Brain; Osmolar Concentration; Renin; Urine; Water-Electrolyte Balance | 2003 |
Effects of angiotensin II and losartan on the growth and proliferation of hepatic stellate cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Division; Cells, Cultured; Drug Combinations; Hepatocytes; Liver Cirrhosis; Losartan; Male; Rats; Rats, Sprague-Dawley | 2003 |
Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver.
Topics: Ammonia; Angiotensin II; Blood Volume; Female; Glomerular Filtration Rate; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Radioimmunoassay; Regional Blood Flow; Renin; Sodium; Sodium Chloride | 2003 |
REDUCED VASCULAR RESPONSE TO ANGIOTENSIN II IN SECONDARY HYPERALDOSTERONISM.
Topics: Angiotensin II; Angiotensins; Blood Pressure; Heart Failure; Humans; Hyperaldosteronism; Liver Cirrhosis; Nephrotic Syndrome; Pharmacology | 1963 |
THE EFFECT OF ANGIOTENSIN II ON THE BLOOD PRESSURE IN HUMANS WITH HYPERTENSIVE DISEASE.
Topics: Acidosis; Angiotensin II; Angiotensins; Aortic Coarctation; Biomedical Research; Blood Pressure; Glomerulonephritis; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hypertension, Renal; Infusions, Parenteral; Kidney; Kidney Diseases; Liver Cirrhosis; Norepinephrine; Pharmacology; Sodium Chloride | 1964 |
[DIURETIC THERAPY OF THE ASCITIC FORM OF LIVER CIRRHOSIS WITH ANGIOTENSIN II AND THE MECHANISM OF ITS ACTION].
Topics: Angiotensin II; Angiotensins; Ascites; Diuresis; Diuretics; Drug Therapy; Humans; Kidney Glomerulus; Liver Cirrhosis; Spironolactone | 1964 |
[SODIUM DIURESIS AFTER ANGIOTENSIN II. (HYPERTENSIN CIBA) IN LIVER CIRRHOSIS, ITS MECHANISM AND CLINICAL USE].
Topics: Angiotensin Amide; Angiotensin II; Angiotensins; Diuresis; Humans; Liver Cirrhosis; Pharmacology; Sodium | 1964 |
STUDIES ON THE RESPONSES TO INTRAVENOUS ANGIOTENSIN II IN NORMAL SUBJECTS AND IN CIRRHOSIS OF THE LIVER.
Topics: Angiotensin II; Angiotensins; Biomedical Research; Blood Pressure; Blood Pressure Determination; Electrocardiography; Heart Rate; Humans; Injections, Intravenous; Liver Cirrhosis; Pharmacology; Pulse; Toxicology | 1965 |
PROLONGED INFUSIONS OF ANGIOTENSIN II AND NOREPINEPHRINE AND BLOOD PRESSURE, ELECTROLYTE BALANCE, AND ALDOSTERONE AND CORTISOL SECRETION IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES.
Topics: Aldosterone; Angiotensin II; Angiotensins; Ascites; Blood Pressure; Body Fluids; Dexamethasone; Humans; Hydrocortisone; Hypertension; Liver Cirrhosis; Male; Metabolism; Natriuresis; Norepinephrine; Pharmacology; Potassium; Sodium; Sodium, Dietary; Tachyphylaxis; Urine; Water-Electrolyte Balance | 1965 |
Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensinogen; Blood Volume; Case-Control Studies; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney; Liver; Liver Cirrhosis; Male; Middle Aged; Peptidyl-Dipeptidase A; Prospective Studies; Renal Circulation; Renin; Survival Analysis | 2004 |
The answer: angiotensin II. The question: what do inflammation, oxidant stress and fibrogenesis have in common?
Topics: Angiotensin II; Fibrinogen; Humans; Inflammation; Liver Cirrhosis; Oxidative Stress; Vasoconstriction | 2004 |
Expression of AT(1a) mRNA in rat hepatic stellate cells and its effects on cell growth collagen production.
Topics: Angiotensin II; Animals; Base Sequence; Cell Division; Collagen; Liver; Liver Cirrhosis; Molecular Sequence Data; Proline; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger | 2004 |
Effects of sympathetic nerves and angiotensin II on renal sodium and water handling in rats with common bile duct ligature.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Body Weight; Common Bile Duct; Dose-Response Relationship, Drug; Ligation; Liver Cirrhosis; Male; Naphthyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Sodium; Sympathetic Nervous System; Vasoconstrictor Agents; Water | 2005 |
Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats.
Topics: Angiotensin II; Animals; Cells, Cultured; Common Bile Duct; Hepatitis; Hepatocytes; Hypertension; Ligation; Liver Cirrhosis; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Thrombosis; Vasoconstrictor Agents | 2005 |
[Effects of angiotensin II and aldosterone on NF-kappaB binding activity in hepatic stellate cells].
Topics: Aldosterone; Angiotensin II; Animals; DNA-Binding Proteins; I-kappa B Proteins; Liver; Liver Cirrhosis; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Rats; Rats, Wistar; Signal Transduction | 2005 |
Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression.
Topics: Angiotensin II; Animals; Antigens, CD; Cell Line; Chemokine CCL2; Hepatitis; Hepatocytes; Humans; Intracellular Signaling Peptides and Proteins; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Protein Serine-Threonine Kinases; Receptor, Angiotensin, Type 1; rho-Associated Kinases; RNA, Messenger | 2005 |
The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of Angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Animals; Cytoprotection; Hydroxyproline; Liver; Liver Cirrhosis; Male; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Transforming Growth Factor beta1 | 2007 |
Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins.
Topics: Angiotensin II; Animals; Aorta; Arrestins; beta-Adrenergic Receptor Kinases; beta-Arrestin 2; beta-Arrestins; Calcium; G-Protein-Coupled Receptor Kinase 2; GTP-Binding Proteins; Hepatic Artery; Humans; Intracellular Signaling Peptides and Proteins; Liver Cirrhosis; Male; Microfilament Proteins; Myosin-Light-Chain Phosphatase; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; rho-Associated Kinases; Vasoconstriction | 2007 |
Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
Topics: Alanine Transaminase; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aspartate Aminotransferases; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Choline Deficiency; Disease Models, Animal; DNA Damage; Fatty Liver; Liver; Liver Cirrhosis; Male; Organ Size; Oxidative Stress; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Wistar; Reactive Oxygen Species; rho GTP-Binding Proteins; rho-Associated Kinases; RNA, Messenger; Signal Transduction; Tetrazoles; Time Factors; Tumor Necrosis Factor-alpha | 2007 |
ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats.
Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Disease Models, Animal; Fatty Liver; Interleukin-6; Irbesartan; Liver; Liver Cirrhosis; Male; Metabolic Syndrome; Obesity; Perindopril; Rats; Rats, Zucker; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2008 |
Angiotensin II type 1 receptor antagonist improves the prognosis in rats displaying liver cirrhosis induced by a choline-deficient diet.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Choline; Disease Models, Animal; Imidazoles; Lipid Peroxidation; Liver Cirrhosis; Male; Pyridines; Rats; Rats, Inbred F344; Tetrazoles; Vasoconstrictor Agents | 2008 |
[Plasma aldosterone in compensated liver cirrhosis].
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Angiotensin II; Circadian Rhythm; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Renin-Angiotensin System | 1984 |
Role of renal kallikrein in the derangement of sodium and water excretion in cirrhotic patients.
Topics: Adult; Aged; Aldosterone; Alprostadil; Angiotensin II; Body Water; Female; Humans; Infusions, Parenteral; Kallikreins; Kidney; Kidney Function Tests; Kinins; Liver Cirrhosis; Male; Middle Aged; Prostaglandins E; Renin; Sodium | 1984 |
[Estimation of plasma renin, angiotensin II and urinary aldosterone in patients with cirrhosis of liver and its clinical significance].
Topics: Adult; Aged; Aldosterone; Angiotensin II; Ascites; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Renin | 1982 |
Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Cardiac Output; Hemodynamics; Humans; Liver Circulation; Liver Cirrhosis; Renin; Renin-Angiotensin System; Saralasin; Vascular Resistance | 1981 |
Sodium status and the renin-angiotensin-aldosterone system in compensated liver disease.
Topics: Adult; Aldosterone; Analysis of Variance; Angiotensin II; Chronic Disease; Female; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Renin; Sodium | 1981 |
Acute effects of saralasin on plasma aldosterone in different pathophysiological conditions.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Child; Diet, Sodium-Restricted; Female; Furosemide; Humans; Hydrocortisone; Hypertension; Liver Cirrhosis; Male; Middle Aged; Renin; Saralasin | 1980 |
Renin-angiotensin-aldosterone in cirrhotic ascites.
Topics: Aldosterone; Angiotensin II; Ascites; Humans; Liver Cirrhosis; Renin | 1980 |
Renin-angiotensin-aldosterone system in cirrhosis.
Topics: Acute Kidney Injury; Aldosterone; Angiotensin II; Ascites; Blood Volume; Edema; Extracellular Space; Homeostasis; Humans; Liver Cirrhosis; Renin; Sodium | 1980 |
Angiotensin-induced sodium excretion patterns in cirrhosis: role of renal prostaglandins.
Topics: Angiotensin II; Hemodynamics; Humans; Liver Cirrhosis; Natriuresis; Prostaglandins E; Sodium | 1982 |
Effect of the serine protease inhibitor, aprotinin, on systemic haemodynamics and renal function in patients with hepatic cirrhosis and ascites.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Aprotinin; Ascites; Blood Pressure; Female; Glomerular Filtration Rate; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Regional Blood Flow; Renal Circulation; Renin; Sodium; Vascular Resistance | 1994 |
Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Ascites; Atrial Natriuretic Factor; Cyclic GMP; Dinoprostone; Endothelins; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Renal Plasma Flow, Effective; Sodium; Urination | 1995 |
Parathyroid hormone in blood pressure and volume homeostasis in healthy subjects, hyperparathyroidism, liver cirrhosis and glomerulonephritis. A possible interaction with angiotensin II and atrial natriuretic peptide.
Topics: Adolescent; Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Female; Furosemide; Glomerulonephritis; Humans; Hyperparathyroidism; Immunoradiometric Assay; Liver Cirrhosis; Male; Middle Aged; Norepinephrine; Parathyroid Hormone | 1994 |
Pathophysiological characteristics of cutaneous microcirculation in patients with liver cirrhosis: relationships to cardiovascular hemodynamics and plasma neurohormonal factors.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Cardiovascular System; Female; Hemodynamics; Hormones; Humans; Liver Cirrhosis; Male; Microcirculation; Middle Aged; Norepinephrine; Renin; Skin; Vasoactive Intestinal Peptide | 1993 |
Mechanisms of changes in renal handling of sodium following transjugular intrahepatic portal systemic stent-shunt (TIPSS).
Topics: Adult; Angiotensin II; Ascites; Female; Guanosine Monophosphate; Humans; Kidney Function Tests; Lithium; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Prognosis; Prospective Studies; Radioimmunoassay; Reference Values; Renin; Severity of Illness Index; Sodium | 1996 |
The correction of autonomic dysfunction in cirrhosis by captopril.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Electrocardiography; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Reflex; Vagus Nerve | 1997 |
Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites.
Topics: Angiotensin II; Arachidonate 15-Lipoxygenase; Arachidonate 5-Lipoxygenase; Ascites; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipoxins; Liver Cirrhosis; Neutrophils; RNA, Messenger | 1998 |
Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Female; Forearm; Humans; Liver Cirrhosis; Losartan; Male; Middle Aged; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Renin-Angiotensin System; Sympathetic Nervous System; Sympathomimetics; Vascular Resistance | 1998 |
Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis.
Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Ascites; Dose-Response Relationship, Drug; Hemodynamics; Homeostasis; Humans; Kidney; Liver Cirrhosis; Losartan; Male; Middle Aged; Sodium | 2000 |
Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis.
Topics: Adult; Angiotensin II; Antihypertensive Agents; Blood Vessels; Disease Progression; Dose-Response Relationship, Drug; Female; Forearm; Hemodynamics; Humans; Liver Cirrhosis; Losartan; Lower Body Negative Pressure; Male; Middle Aged; Norepinephrine; Regional Blood Flow; Sympathetic Nervous System; Vasoconstrictor Agents; Vasomotor System | 2000 |
Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure.
Topics: Analysis of Variance; Angiotensin II; Female; Glomerular Filtration Rate; Humans; Liver Cirrhosis; Male; Middle Aged; Portal Pressure; Portasystemic Shunt, Transjugular Intrahepatic; Renal Plasma Flow; Sodium | 2000 |
Losartan and renal sodium handling.
Topics: Angiotensin II; Antihypertensive Agents; Humans; Liver Cirrhosis; Losartan; Natriuresis | 2000 |
Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: evidence for a receptor-specific mechanism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Angiotensin II; Female; GTP-Binding Proteins; Hepatic Artery; Humans; In Vitro Techniques; Liver Cirrhosis; Male; Middle Aged; Receptors, Cell Surface; Sodium Fluoride; Tissue Donors; Vasoconstriction; Vasoconstrictor Agents | 2001 |
[The levels of renin activity, angiotensin converting enzyme and angiotensin II in cirrhotic patients with ascites undergoing portacaval shunt].
Topics: Adult; Aged; Angiotensin II; Ascites; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Peptidyl-Dipeptidase A; Portacaval Shunt, Surgical; Portal Pressure; Renin | 1999 |
Effect of 1-week losartan administration on bile duct-ligated cirrhotic rats with portal hypertension.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blotting, Western; Common Bile Duct; Enzyme Inhibitors; Hematocrit; Hypertension, Portal; Ligation; Liver Circulation; Liver Cirrhosis; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Norepinephrine; Plasma Volume; Rats; Rats, Sprague-Dawley; Renin | 2002 |
Impaired cardiovascular responsiveness in liver disease.
Topics: Angiotensin II; Blood Vessels; Cardiovascular System; Epinephrine; Forearm; Hand; Heart Rate; Humans; Liver Cirrhosis; Norepinephrine; Peripheral Nerves; Pulse; Reflex; Regional Blood Flow; Stimulation, Chemical | 1975 |
[Renin-angiotensin system in hepatic cirrhosis].
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Dogs; Humans; Juxtaglomerular Apparatus; Liver Cirrhosis; Potassium; Renin; Sodium; Water-Electrolyte Balance | 1979 |
Renal hemodynamics and the renin--angiotensin system in cirrhosis: relationship to sodium retention.
Topics: Angiotensin II; Humans; Kidney; Liver Cirrhosis; Natriuresis; Renin; Sodium | 1979 |
Blood pressure response to [1-sarcosine, 8-isoleucine] angiotensin II in patients with liver cirrhosis and ascites.
Topics: Aldosterone; Angiotensin II; Ascites; Blood Pressure; Humans; Liver Cirrhosis; Renin | 1979 |
[Secondary hyperaldosteronism in patients with liver cirrhosis, frequently caused by therapy].
Topics: Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Diuretics; Glucuronates; Humans; Hyperaldosteronism; Liver Cirrhosis; Potassium; Sodium | 1979 |
Total immunoreactive angiotensin ii, its hepta-octapeptide fraction, and its hexapeptide in patients with liver disease.
Topics: Adult; Angiotensin II; Arteries; Ascites; Female; Hepatitis B; Humans; Liver Cirrhosis; Male; Middle Aged; Oligopeptides; Peptide Fragments; Renin; Veins | 1978 |
Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensinogen; Ascites; Diuretics; Humans; Liver Cirrhosis; Middle Aged; Renin | 1978 |
[Renal perfusion and the renin-angiotensin system in hepatic cirrhosis].
Topics: Acute Kidney Injury; Aldosterone; Angiotensin II; Humans; Kidney; Kidney Function Tests; Liver Cirrhosis; Natriuresis; Renin | 1978 |
Role of renin-angiotensin system in the controls of blood pressure and aldosterone in patients with cirrhosis and ascites.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Ascites; Blood Pressure; Depression, Chemical; Female; Humans; Infusions, Parenteral; Liver Cirrhosis; Male; Middle Aged; Renin; Saralasin | 1978 |
Studies of volume homeostasis in man utilizing the model of head-out water immersion.
Topics: Aldosterone; Angiotensin II; Extracellular Space; Homeostasis; Humans; Immersion; Liver Cirrhosis; Models, Biological; Natriuresis; Plasma Volume; Potassium; Renin; Sodium; Water | 1978 |
Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Humans; Liver Cirrhosis; Renin; Saralasin | 1976 |
[Kideny and hepato-biliary diseases].
Topics: Abdomen; Acidosis; Acute Kidney Injury; Aldosterone; Angiotensin II; Biliary Tract Diseases; Glomerular Filtration Rate; Hepatic Encephalopathy; Humans; Kidney; Kidney Diseases; Kidney Glomerulus; Liver Cirrhosis; Liver Diseases; Natriuresis; Pressure; Renin; Water | 1976 |
[The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)].
Topics: Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Blood Pressure; Diuresis; Female; Heart Rate; Humans; Hyperaldosteronism; Kidney; Liver Cirrhosis; Male; Middle Aged; Renin; Saralasin | 1976 |
Plasma angiotensin activity in cirrhosis of the liver and idiopathic portal hypertension.
Topics: Angiotensin II; Hepatitis A; Humans; Hypertension, Portal; Liver Cirrhosis | 1976 |
Heterogeneity of renin substrate in human plasma: effect of pregnancy and oral contraceptives.
Topics: Angiotensin II; Angiotensinogen; Contraceptives, Oral; Electrophoresis, Polyacrylamide Gel; Female; Humans; Liver Cirrhosis; Male; Nephrectomy; Pregnancy | 1976 |
Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
Topics: Acidosis, Renal Tubular; Aldosterone; Angiotensin II; Bartter Syndrome; Blood Pressure; Cushing Syndrome; Edema; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hypertension, Renal; Kidney Failure, Chronic; Liver Cirrhosis; Nephrotic Syndrome; Pheochromocytoma; Renin; Sodium; Time Factors; Water-Electrolyte Imbalance | 1976 |
[Hyperaldosteronism in acute viral hepatitis, liver cirrhosis and fulminating liver failure].
Topics: Aldosterone; Angiotensin II; Angiotensinogen; Corticosterone; Hepatic Encephalopathy; Hepatitis; Humans; Hydrocortisone; Hyperaldosteronism; Liver Cirrhosis; Liver Diseases; Renin | 1976 |
[Abdominal visceral pharmacoangiography].
Topics: Abdomen; Abdominal Neoplasms; Angiography; Angiotensin II; Celiac Artery; Gastrointestinal Hemorrhage; Hepatic Artery; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Diseases; Pancreatic Diseases; Renal Artery Obstruction | 1975 |
[Letter: Hyponatremia in cirrhosis and beta blocking agents].
Topics: Angiotensin II; Humans; Hyperaldosteronism; Hyponatremia; Liver Cirrhosis; Propranolol; Renin; Water-Electrolyte Balance | 1975 |
[Blood pressure behavior and pathomorphology in the rat following application of high doses of depot angiotensin].
Topics: Angiotensin II; Animals; Blood Pressure; Death; Delayed-Action Preparations; Intestines; Kidney; Liver; Liver Cirrhosis; Male; Myocardium; Rats | 1975 |
[Renin and aldosterone].
Topics: Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertension; Juxtaglomerular Apparatus; Liver Cirrhosis; Radioimmunoassay; Renin | 1975 |
[The fole of the renin-angiotensin system in secondary aldosteronism (author's transl)].
Topics: Adolescent; Adult; Aged; Angiotensin II; Female; Heart Failure; Humans; Hyperaldosteronism; Hypertension, Malignant; Hypertension, Renal; Liver Cirrhosis; Male; Middle Aged; Nephrotic Syndrome; Renin | 1975 |
Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Captopril; Creatinine; Cyclic GMP; Diuresis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Furosemide; Humans; Kidney; Liver; Liver Cirrhosis; Male; Middle Aged; Renal Dialysis; Renin; Sodium; Spironolactone | 1992 |
Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Disease Models, Animal; Humans; Kidney; Liver Cirrhosis; Norepinephrine; Rats | 1992 |
[Effects of autogenous reinfusion of ascitic fluid on plasma atrial natriuretic peptide and renin activity in cirrhotic patients].
Topics: Adult; Aged; Angiotensin II; Ascitic Fluid; Atrial Natriuretic Factor; Humans; Infusions, Intravenous; Liver Cirrhosis; Male; Middle Aged; Peritoneal Lavage; Renin | 1992 |
[Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration].
Topics: Angiotensin II; Ascites; Atrial Natriuretic Factor; Female; Glomerular Filtration Rate; Humans; Hypotension; Kidney Function Tests; Kidney Tubules; Lithium; Liver Cirrhosis; Male; Middle Aged; Renin; Sodium | 1991 |
Impaired pressor reactivity in cirrhosis: evidence for a peripheral vascular defect.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Female; Heart Rate; Humans; Isoproterenol; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Nordefrin; Norepinephrine; Phenylephrine; Reference Values; Vascular Diseases | 1991 |
Clinical evaluation of angiotensin II enhanced perfusion scintigraphy in metastatic liver disease.
Topics: Angiotensin II; Diagnosis, Differential; Evaluation Studies as Topic; Gastrointestinal Neoplasms; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Neoplasms; Perfusion; Radionuclide Imaging | 1989 |
The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
Topics: Aldosterone; Angiotensin II; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Renin; Renin-Angiotensin System; Sodium | 1985 |
[Determination of renin activity in blood plasma].
Topics: Angiotensin II; Animals; Ascites; Humans; Hypertension; Hypertension, Renal; Liver Cirrhosis; Male; Methods; Rats; Renin | 1970 |
[Blood plasma content of angiotensinogen in arterial hypertension, circulatory insufficiency, myocardial infarct and liver cirrhosis].
Topics: Adrenal Glands; Alpha-Globulins; Angiotensin II; Chronic Disease; Glomerulonephritis; Glucocorticoids; Heart Failure; Humans; Hypertension; Liver; Liver Cirrhosis; Myocardial Infarction; Renin | 1972 |
The estimation of renin in human plasma.
Topics: Angiotensin II; Ascites; Blood Chemical Analysis; Endopeptidases; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Liver Cirrhosis; Plasma; Renin | 1964 |
[Suppression by spirolactones of the natriuretic effect of angiotensin peculiar to certain cirrhotics].
Topics: Angiotensin II; Humans; Liver Cirrhosis; Natriuresis; Spironolactone | 1965 |
Evaluation of indices of juxtaglomerular cells and zona glomerulosa in human and experimental cirrhosis.
Topics: Adrenal Glands; Angiotensin II; Animals; Carbon Tetrachloride Poisoning; Humans; Hypertension, Renal; Juxtaglomerular Apparatus; Kidney Glomerulus; Liver Cirrhosis; Liver Cirrhosis, Experimental; Microscopy, Electron; Rats; Renin | 1966 |
[Studies on the renal cortex blood flow under the influence of vasopressor substances by means of the Hensel sound].
Topics: Adult; Angiotensin II; Blood Circulation; Epinephrine; Female; Humans; Hypotension; Kidney; Liver Cirrhosis; Male; Middle Aged; Norepinephrine | 1965 |
Plasma angiotensinase activity in liver disease.
Topics: Adult; Angiotensin II; Animals; Blood Pressure; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Cholestasis; Clinical Enzyme Tests; Electrophoresis; Endopeptidases; Enzymes; Hepatitis A; Humans; Liver Cirrhosis; Middle Aged; Rabbits | 1965 |
Angiotensin-induced natriuresis in cirrhosis in the absence of endogenous aldosterone secretion.
Topics: Aldosterone; Angiotensin II; Ascites; Female; Humans; In Vitro Techniques; Liver Cirrhosis; Middle Aged; Natriuresis; Norepinephrine | 1966 |
The effects of aldosterone and angiotensin on renal function.
Topics: Adult; Aldosterone; Angiotensin II; Ascites; Edema; Female; Humans; In Vitro Techniques; Kidney; Kidney Function Tests; Liver Cirrhosis; Male; Middle Aged; Natriuresis; Nephrotic Syndrome; Potassium | 1966 |
Angiotensin blood levels in hypertensive and non-hypertensive diseases.
Topics: Acute Kidney Injury; Angiotensin II; Glomerulonephritis; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Liver Cirrhosis; Pyelonephritis | 1966 |
Measurement of renin and substrate concentrations in human serum.
Topics: Adolescent; Adult; Angiotensin II; Animals; Antimetabolites; Ascites; Biological Assay; Endopeptidases; Female; Humans; Hydrogen-Ion Concentration; Hypertension; Hypertension, Malignant; Liver Cirrhosis; Male; Middle Aged; Pregnancy; Rats; Renin; Swine | 1966 |
[Angiotensin intradermoreaction in patients with liver cirrhosis in the ascitic phase. Results and interpretation in relation to the pathogenesis of the altered hydrosaline metabolism in cirrhogenic liver diseases].
Topics: Aldosterone; Angiotensin II; Ascites; Diabetes Insipidus; Heart Failure; Humans; Hypertension; Jaundice; Liver Cirrhosis; Renin; Skin Tests; Sodium Chloride; Water | 1966 |
[The effect of an angiotensin infusion on the renal water-electrolyte excretion in liver cirrhosis and hydropic heart insufficiency].
Topics: Angiotensin II; Heart Failure; Humans; Infusions, Parenteral; Kidney Function Tests; Liver Cirrhosis; Water-Electrolyte Balance | 1965 |
Role of aldosterone in edema formation.
Topics: Aldosterone; Angiotensin II; Edema; Heart Failure; Humans; Hyperaldosteronism; Kidney; Liver; Liver Cirrhosis; Natriuresis; Nephrotic Syndrome; Renin; Secretory Rate | 1966 |
Plasma renin activity and renin-substrate concentration in patients with liver disease.
Topics: Angiotensin II; Ascites; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Renin | 1967 |
Renal failure in patients with cirrhosis of the liver. 3. Evaluation of intrarenal blood flow by para-aminohippurate extraction and response to angiotensin.
Topics: Adult; Aminohippuric Acids; Angiotensin II; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Kidney Function Tests; Liver Cirrhosis; Male; Middle Aged; Sodium; Urine | 1967 |
[The value of the angiotensin infusion test in differential diagnosis].
Topics: Angiotensin II; Glomerulonephritis; Heart Failure; Humans; Hypertension; Liver Cirrhosis; Metaraminol | 1967 |
[Results of the determination of plasma renin].
Topics: Anemia; Angiotensin II; Cushing Syndrome; Diagnosis, Differential; Female; Heart Failure; Humans; Hyperaldosteronism; Hypertension, Renal; Hyperthyroidism; Liver Cirrhosis; Nephritis; Pregnancy; Pregnancy Complications; Pyelonephritis; Renin; Sodium | 1967 |
Angiotensin-aldosterone interrelationship in liver cirrhosis.
Topics: Aldosterone; Angiotensin II; Humans; Liver Cirrhosis | 1967 |
[Effects of angiotensin on the kidney in liver cirrhosis].
Topics: Angiotensin II; Ascites; Diet, Sodium-Restricted; Diuresis; Edema; Humans; Kidney; Kidney Function Tests; Liver Cirrhosis; Mannitol; Natriuresis; Perfusion | 1967 |
Serum angiotensinase activity in cirrhosis.
Topics: Aminopeptidases; Angiotensin II; Bilirubin; Endopeptidases; Hepatitis; Humans; Hyperaldosteronism; Hyponatremia; Liver Cirrhosis; Renin | 1968 |
Effect of angiotensin and norepinephrine upon urate clearance in man.
Topics: Adolescent; Adult; Angiotensin II; Diuresis; Glomerular Filtration Rate; Humans; Hypertension, Portal; Injections, Intravenous; Kidney; Liver Cirrhosis; Male; Norepinephrine; Potassium; Sodium; Uric Acid | 1968 |
Effects of furosemide uring antidiuresis and antinatriuresis induced by angiotensin.
Topics: Angiotensin II; Diuresis; Furosemide; Glomerular Filtration Rate; Humans; Iodine Isotopes; Kidney; Liver Cirrhosis; Natriuresis; Potassium; Sodium; Spironolactone; Water-Electrolyte Balance | 1967 |
Angiotensinase activity using human crude angiotensin.
Topics: Angiotensin II; Centrifugation; Endopeptidases; Glomerulonephritis; Hepatitis; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Kidney; Liver; Liver Cirrhosis; Renin | 1968 |
[Studies on the blood flow of the human kidney following operations on the abdomen].
Topics: Abdomen; Adult; Aged; Angiotensin II; Blood Volume; Diabetes Complications; Diuresis; Female; Humans; Hyperaldosteronism; Kidney; Liver Cirrhosis; Male; Middle Aged; Norepinephrine; Postoperative Complications; Regional Blood Flow; Renal Artery; Vascular Resistance; Vasomotor System | 1966 |
Plasma renin and angiotensinogen levels in pathological states associated with oedema.
Topics: Adolescent; Angiotensin II; Child; Child, Preschool; Edema; Glomerulonephritis; Heart Failure; Humans; Infant; Liver Cirrhosis; Liver Diseases; Nephrotic Syndrome; Protein-Losing Enteropathies; Renin | 1968 |
[The physiological relationship between the renin-angiotensin system and aldosterone].
Topics: Adult; Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Female; Heart Failure; Humans; Hyperaldosteronism; Liver Cirrhosis; Nephrotic Syndrome; Norepinephrine; Pregnancy; Radiography; Renal Artery Obstruction; Renin; Sodium | 1965 |
[Studies on renin-angiotensin system. I. Angiotensinase activities in hepatic disorders].
Topics: Adult; Angiotensin II; Animals; Bile Duct Neoplasms; Biliary Tract Diseases; Blood Pressure; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Chloramphenicol; Endopeptidases; Erythromycin; Female; Gout; Hepatitis; Humans; Hypertension; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms; Male; Mercaptopurine; Middle Aged; Nephrotic Syndrome; Rats | 1968 |
[Effect of angiotensin and nonadrenaline in pressor and non pressor doses on the urinary secretion of sodium in uncompensated cirrhotic patients].
Topics: Angiotensin II; Glomerular Filtration Rate; Humans; Liver Cirrhosis; Norepinephrine; Sodium; Water-Electrolyte Balance | 1967 |
Effect of angiotensin II on urinary sodium excretion in normal subjects and in cirrhotic patients.
Topics: Angiotensin II; Diet; Diuresis; Glomerular Filtration Rate; Humans; Kidney Function Tests; Kidney Glomerulus; Liver Cirrhosis; Sodium | 1968 |
[Renal insufficiency in decompensated liver cirrhosis. Report of 5 cases and a review of the pathophysiology].
Topics: Aged; Angiotensin II; Anuria; Humans; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Portal System | 1968 |
Acute renal vein hypertension: oliguria, hormone infusion, and volume expansion.
Topics: Acute Disease; Aldosterone; Angiotensin II; Animals; Anuria; Dogs; Glomerular Filtration Rate; Hypertension, Renal; Kidney; Liver Cirrhosis; Male; Organ Size; Renal Veins; Renin; Sodium; Vasopressins | 1969 |
[Transient anuria in decompensated liver cirrhosis during angiotensin (Hypertensin) infusion].
Topics: Angiotensin II; Anuria; Diuresis; Humans; Liver Cirrhosis; Male; Middle Aged; Natriuresis | 1969 |
[Diagnostic significance of the angiotensin infusion test].
Topics: Adolescent; Adult; Aged; Angiotensin II; Child; Diabetic Nephropathies; Female; Glomerulonephritis; Heart Diseases; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Infusions, Parenteral; Liver Cirrhosis; Male; Metaraminol; Middle Aged; Nephritis | 1968 |
[Secondary hyperaldosteronisms].
Topics: Aldosterone; Angiotensin II; Heart Failure; Hyperaldosteronism; Hyperkalemia; Hypertension, Malignant; Hypertension, Renal; Hypokalemia; Kidney Failure, Chronic; Liver Cirrhosis; Norepinephrine; Pheochromocytoma; Potassium; Renin; Stimulation, Chemical | 1969 |
[Contribution to the study of the interference of the renin-angiotensin-aldosterone system during the development of chronic alcoholic hepatopathy].
Topics: Adult; Alcoholism; Angiotensin II; Blood Volume; Fatty Liver; Female; Humans; Hyperaldosteronism; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Natriuresis; Potassium; Renin | 1968 |
[Intravenous infusion of angiotensin for the diagnosis of arterial hypertension (Kaplan-Silah test)].
Topics: Adolescent; Adult; Angiotensin II; Humans; Hypertension; Injections, Intravenous; Liver Cirrhosis; Middle Aged; Renal Artery Obstruction | 1969 |
[Inhibition of natriuretic effect of angiotensin by spirolactones and salidiuretics in cirrhosis and arterial hypertension].
Topics: Angiotensin II; Chlorthalidone; Creatinine; Depression, Chemical; Diet, Sodium-Restricted; Glomerular Filtration Rate; Humans; Hypertension; Inulin; Kidney Tubules; Liver Cirrhosis; Natriuresis; Norepinephrine; Potassium; Spironolactone; Water | 1969 |
Failure of the cirrhotic liver to inactivate renin: evidence for a splanchnic source of renin-like activity.
Topics: Adult; Aged; Angiotensin II; Animals; Biological Assay; Dogs; Female; Hepatic Veins; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Renin | 1969 |
[Activity of aminopeptidase towards angiotensin II-amide in the serum during normal health, pregnancy, hypertension and liver disease].
Topics: Adult; Aged; Angiotensin II; Cholestasis; Endopeptidases; Female; Hepatitis A; Humans; Hypertension; Leucyl Aminopeptidase; Liver Cirrhosis; Middle Aged; Pregnancy | 1969 |
Anti angiotensin activity of plasma and R.B.C. in cirrhosis of liver and nutritional hypoproteinaemia.
Topics: Adolescent; Adult; Angiotensin II; Blood Pressure; Erythrocytes; Humans; Hypoproteinemia; Liver Cirrhosis; Middle Aged | 1969 |
[Intravenous angiotensin test in the differential diagnosis of arterial hypertension].
Topics: Adult; Angiotensin II; Diagnosis, Differential; Humans; Hypertension; Hypertension, Renal; Injections, Intravenous; Liver Cirrhosis; Middle Aged; Pyelonephritis | 1969 |
Liver enzymes in hypertension.
Topics: Adult; Angiotensin II; Blood Pressure Determination; Blood Protein Disorders; Blood Proteins; Chromatography, Paper; Endopeptidases; Enzyme Repression; Female; Humans; Hypertension; Liver; Liver Cirrhosis; Male; Middle Aged | 1970 |
Renal function, renin activity and endogenous vasoactive substances in cirrhosis.
Topics: Alcoholism; Angiotensin II; Ascites; Catecholamines; Dopamine; Glomerular Filtration Rate; Humans; Hydroxyindoleacetic Acid; Kidney; Kidney Diseases; Liver Cirrhosis; Male; Plasma; Regional Blood Flow; Renin; Serotonin | 1970 |
The renin-angiotensin system in experimental cirrhosis.
Topics: Angiotensin II; Animals; Blood Pressure; Endopeptidases; Female; Juxtaglomerular Apparatus; Kidney; Liver Cirrhosis; Nephrectomy; Rats; Renin | 1970 |
Plasma renin level in hepatic cirrhosis. Relaton to functional renal failure.
Topics: Adult; Angiotensin II; Ascites; Cardiac Output; Female; Glomerular Filtration Rate; Humans; Ischemia; Kidney; Kidney Failure, Chronic; Liver; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Natriuresis; Plasma Volume; Posture; Renin; Sodium | 1970 |
[Angiotensin-aldosterone interrelations in hepatic cirrhosis].
Topics: Aldosterone; Angiotensin II; Ascites; Edema; Humans; Liver Cirrhosis; Natriuresis; Potassium | 1970 |
[The salidiuretic interaction of angiotensin II and furosemide in ascitogenic hepatic cirrhosis].
Topics: Angiotensin II; Ascites; Diuresis; Drug Interactions; Electrolytes; Female; Furosemide; Humans; Kidney; Liver Cirrhosis; Male | 1969 |
[Clinical studies on the relation between aldosterone and various hypertensive and renal diseases. 2. Studies on the effect of synthetic angiotensin II on aldosterone secretion rate].
Topics: Addison Disease; Aldosterone; Angiotensin II; Blood Pressure; Humans; Hypertension; Injections, Intravenous; Liver Cirrhosis; Renal Artery Obstruction; Secretory Rate; Thyroiditis; Time Factors; Tritium | 1971 |
[The epidermolysis syndrome (Lyell) from the viewpoint of internal medicine].
Topics: Acute Disease; Aged; Angiotensin II; Cardiomegaly; Cholangitis; Chronic Disease; Diabetes Complications; Glomerulonephritis; Humans; Liver Cirrhosis; Male; Methicillin; Middle Aged; Pancreatic Diseases; Potassium; Prednisolone; Prognosis; Stevens-Johnson Syndrome | 1970 |
[Changes of serum angiotensionogen concentration in acute hepatitis and liver cirrhosis].
Topics: Acute Disease; Angiotensin II; Hepatitis A; Humans; Liver Cirrhosis; Renin | 1972 |
[Hepatic extraction and clearance of renin in liver cirrhosis].
Topics: Adult; Aged; Angiotensin II; Blood Chemical Analysis; Blood Circulation Time; Female; Hepatic Veins; Humans; Indocyanine Green; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Renin; Venous Pressure | 1972 |
[Effect of angiotensin on cirrhotics].
Topics: Angiotensin II; Ascites; Blood Pressure; Diuresis; Electrolytes; Humans; Kidney; Liver; Liver Cirrhosis | 1972 |
[The angiotensinase activity of -L-asparaginyl aminopeptidase in the serum of normal subjects, in patients with hepatobiliary diseases and during pregnancy].
Topics: Adult; Aged; Alkaline Phosphatase; Aminopeptidases; Angiotensin II; Asparagine; Biliary Tract Diseases; Cholelithiasis; Cholestasis; Endopeptidases; Female; Humans; Kinetics; Liver Cirrhosis; Liver Diseases; Male; Methods; Middle Aged; Pregnancy | 1972 |
Vasopressor-induced natriuresis and altered intrarenal haemodynamics in cirrhotic man.
Topics: Aminohippuric Acids; Angiotensin II; Diuresis; Glomerular Filtration Rate; Humans; Kidney; Liver Cirrhosis; Male; Metabolic Clearance Rate; Natriuresis; Norepinephrine; Potassium; Radioisotopes; Regional Blood Flow; Stimulation, Chemical; Xenon | 1973 |
[Determination of plasma renin activity in edematous cirrhosis. Influence of various depletive treatments].
Topics: Adrenal Cortex Hormones; Aldosterone; Angiotensin II; Cardanolides; Diet, Sodium-Restricted; Diuretics; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Ketosteroids; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Potassium; Renin; Sodium | 1973 |
The control of renal cortical perfusion by the renin angiotensin system.
Topics: Angiotensin II; Animals; Dogs; Humans; Kidney; Kidney Cortex; Liver Cirrhosis; Microcirculation; Perfusion; Radioisotopes; Regional Blood Flow; Renin; Rubber; Silicones; Sodium; Swine; Urine; Xenon | 1974 |
Impaired left ventricular function in alcoholic cirrhosis with ascites. Ineffectiveness of ouabain.
Topics: Adult; Alcoholism; Angiotensin II; Ascites; Cardiac Output; Heart Ventricles; Hemodynamics; Humans; Liver Cirrhosis; Male; Middle Aged; Ouabain; Vascular Resistance | 1974 |
Pulmonary generation and peripheral uptake of endogenous angiotensin II in man.
Topics: Angiotensin II; Aorta; Coronary Disease; Coronary Vessels; Hepatic Veins; Humans; Liver Cirrhosis; Pulmonary Artery; Radioimmunoassay | 1973 |
Response of plasma aldosterone to postural change, diuretica, angiotensin II, sodium restriction or loading and prostaglandin.
Topics: Adrenocortical Hyperfunction; Aldosterone; Angiotensin II; Ascites; Cushing Syndrome; Diet; Diet, Sodium-Restricted; Furosemide; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Liver Cirrhosis; Posture; Prostaglandins; Radioimmunoassay; Sodium; Uremia | 1973 |
Renin, angiotensin II and juxtaglomerular apparatus in liver cirrhosis.
Topics: Adult; Aged; Angiotensin II; Ascites; Autopsy; Chronic Disease; Creatinine; Female; Hepatitis; Humans; Juxtaglomerular Apparatus; Liver Cirrhosis; Male; Middle Aged; Radioimmunoassay; Renin | 1974 |
[Pathogenesis of ascites formation in liver cirrhosis (author's transl)].
Topics: Aldosterone; Angiotensin II; Ascites; Capillary Permeability; Hemodynamics; Humans; Hyperaldosteronism; Hypertension, Portal; Liver Cirrhosis; Lymph; Lymphatic System; Osmotic Pressure; Renin | 1974 |